{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Restrict the search for
m cytarabine
to a specific field?
Status:
Investigational
Source:
NCT04470427: Phase 3 Interventional Completed SARS-CoV-2
(2020)
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Source:
USAN:OPEMALIRSEN SODIUM [USAN]
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Source:
INN:zorevunersen [INN]
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Source:
NCT01191372: Phase 1 Interventional Terminated Hemophilia
(2010)
Source URL:
Class:
NUCLEIC ACID
Status:
Possibly Marketed Outside US
Source:
BLA125796
(2024)
Source URL:
First approved in 2024
Source:
BLA125796
Source URL:
Class:
NUCLEIC ACID